Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia

Explore clinical trials studying Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia trial results

Completed

Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

NCT02412306

Conditions: Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia
Locations: National Hospital Organization Nagoya Medical Center Nagoya, Aichi-ken, Japan

Nagoya University Hospital Nagoya, Aichi-ken, Japan

Kyushu University Hospital Fukuoka, Japan

Gunmaken Saiseikai Maebashi Hospital Maebashi, Gunma, Japan

View all 16 locations

View Trial Details